137 related articles for article (PubMed ID: 23975372)
1. Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues.
Fan CF; Miao Y; Lin XY; Zhang D; Wang EH
Tumour Biol; 2014 Jan; 35(1):765-71. PubMed ID: 23975372
[TBL] [Abstract][Full Text] [Related]
2. Elevated p-CREB-2 (ser 245) expression is potentially associated with carcinogenesis and development of breast carcinoma.
Fan CF; Mao XY; Wang EH
Mol Med Rep; 2012 Feb; 5(2):357-62. PubMed ID: 22052162
[TBL] [Abstract][Full Text] [Related]
3. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance.
Fan C; Zhao Y; Liu D; Zhang X; Wang E
Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of cathepsin D expression in non-small cell lung cancer is conditional on apoptosis-associated protein phenotype: an immunohistochemistry study.
Fan C; Lin X; Wang E
Tumour Biol; 2012 Aug; 33(4):1045-52. PubMed ID: 22302483
[TBL] [Abstract][Full Text] [Related]
6. ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt/β-catenin signaling.
Du J; Liu H; Mao X; Qin Y; Fan C
Int J Med Sci; 2021; 18(6):1442-1448. PubMed ID: 33628101
[TBL] [Abstract][Full Text] [Related]
7. ZCCHC9 promotes proliferation and invasion of lung cancer through regulating the JNK pathway.
Shi X; Jiang B; Liu H; Fan C
J Cell Biochem; 2019 Jun; 120(6):10596-10604. PubMed ID: 30644129
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
10. Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer.
Liu SL; Han Y; Zhang Y; Xie CY; Wang EH; Miao Y; Li HY; Xu HT; Dai SD
Target Oncol; 2012 Jun; 7(2):135-43. PubMed ID: 22585429
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
13. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer.
Chen ZL; Zhao SH; Wang Z; Qiu B; Li BZ; Zhou F; Tan XG; He J
Chin J Cancer; 2011 Jan; 30(1):62-8. PubMed ID: 21192845
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
[TBL] [Abstract][Full Text] [Related]
15. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
16. [Significance of caveolin-1 expression in primary lung cancer].
Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
[TBL] [Abstract][Full Text] [Related]
17. Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression.
Fang C; Jiang B; Shi X; Fan C
Int J Med Sci; 2019; 16(3):470-476. PubMed ID: 30911281
[No Abstract] [Full Text] [Related]
18. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
19. Identifying UBA2 as a proliferation and cell cycle regulator in lung cancer A549 cells.
Jiang B; Fan X; Zhang D; Liu H; Fan C
J Cell Biochem; 2019 Aug; 120(8):12752-12761. PubMed ID: 30848500
[TBL] [Abstract][Full Text] [Related]
20. AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.
Ma Z; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Dai L
Pathol Res Pract; 2017 Oct; 213(10):1257-1263. PubMed ID: 28941723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
